Switzerland: SHS makes first investment from sixth fund: €10m in Simulands

SHS, a Germany-based private equity provider investing in healthcare companies in Europe, has made the first investment from its sixth fund, which held a first close in 2022. It is investing €10m (US$10.6m) in Simulands, a Swiss company providing medical simulation training in the field of structural heart interventions. Simulands enables cardiology teams to train…

You must be a HMI Subscriber to view this content.

Subscribe Now »